BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
93 hedge funds and large institutions have $244M invested in BioSpecifics Technologies Corp. in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 28 reducing their positions, and 4 closing their positions.
325% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 4
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
29% more capital invested
Capital invested by funds: $189M → $244M (+$54.3M)
21% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 28
16% more funds holding
Funds holding: 80 → 93 (+13)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.22M |
| 2 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
+$2.52M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.31M |
| 4 |
EP
Eversept Partners
New York
|
+$1.12M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$8.98M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.86M |
| 3 |
ECP
Elk Creek Partners
Denver,
Colorado
|
-$2.43M |
| 4 |
Millennium Management
New York
|
-$1.58M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.25M |
BSTC Hedge Fund Activity: Q3 2018 in Review
93 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2018, worth a combined $244M — up 29% from $189M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new BSTC positions and 4 closed out — a net gain of 13 holders — while 34 added to existing stakes and 28 trimmed.
The largest buyer was BlackRock, adding an estimated $4.22M. The largest seller was Stonepine Capital Management, cutting an estimated $8.98M.
- 93 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2018, up from 80 in Q2 2018.
- Funds reported $244M of BioSpecifics Technologies Corp. stock for Q3 2018, up 29% quarter-over-quarter.
- 17 funds opened new BioSpecifics Technologies Corp. positions in Q3 2018 and 4 closed out, a net change of +13 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q3 2018 was BlackRock, an estimated $4.22M added.
- The largest BioSpecifics Technologies Corp. seller in Q3 2018 was Stonepine Capital Management, an estimated $8.98M sold.
Based on aggregated 13F filings for Q3 2018.